Julia Hayes, MD | Authors

Preventing Prostate Cancer Overdiagnosis From Becoming Overtreatment

May 12, 2011

The controversy surrounding PSA screening is one of the most heated in oncology. The potential benefits include prevention of prostate cancer morbidity and mortality, but the men potentially harmed through overdiagnosis and overtreatment outnumber those who benefit.